Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_assertion type Assertion NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_head.
- NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_assertion description "[Ongoing clinical trials with pexacerfont and verucerfont in moderately to highly severe dependent anxious alcoholics may yield insight as to the role of CRF(1) receptor antagonists in a personalized medicine approach to treat drug or alcohol dependence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_provenance.
- NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_assertion evidence source_evidence_literature NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_provenance.
- NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_assertion SIO_000772 23294766 NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_provenance.
- NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_assertion wasDerivedFrom befree-20140225 NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_provenance.
- NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_assertion wasGeneratedBy ECO_0000203 NP758430.RAj9uDiFk1tcUF6gJk1OPQOzRqf_XFbNE0cq4zuJpZpa4130_provenance.